23 Dec 2019 10:52
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT
NMC Health plc
London, 23 December 2019: NMC Health (Jersey) Limited, a wholly-owned subsidiary of NMC Health plc, announces that following the launch of a Convertible Bond buyback on 16 December 2019 and the Results of the Invitation of the Convertible Bond Buyback announced on 17 December 2019, the $90 million of convertible bonds have settled today in full using internal cash resources. NMC Health will proceed to cancel the Bonds bought back as soon as possible.
Barclays and J.P. Morgan Cazenove acted as dealer managers (the "Joint Dealer Managers") in respect of the Invitation.
Contacts
NMC Health plc:
Prasanth Manghat, Chief Executive Officer | +971 50 522 5648 |
Prashanth Shenoy, Chief Financial Officer | +971 56 329 0545 |
Asjad Yahya, Investor Relations | +971 56 219 0975 |
Media:
FTI Consulting, LondonEdward Bridges / Simon Conway / Victoria Foster Mitchell | +44 203 727 1000 |
|
|
FTI Consulting, GulfShane Dolan | +971 4 437 2100 |
Barclays (Joint Corporate Broker and Joint Dealer Manager):
5 The North Colonnade Canary Wharf London E14 4BB United Kingdom
Attention: Equity Syndicate Desk Telephone: +44 207 773 8300 Email: equitysynemea@barclays.com
|
|
J.P. Morgan Cazenove (Joint Corporate Broker and Joint Dealer Manager):
25 Bank Street Canary Wharf London E14 5JP United Kingdom
Attention: ECM Syndicate Telephone: +44 207 134 2650 Email: EQL_LM@jpmorgan.com |
|
About NMC
NMC is one of the leading private healthcare operators in the Gulf Cooperation Council ("GCC") with an international network of multi-specialty inpatient and outpatient clinics and hospitals, specialized maternity and fertility clinics, and long-term care homes hospitals across nineteen countries. NMC also ranks as one of the top two in-vitro fertilisation operators globally. The NMC Health group is recognised as a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing a selective international expansion programme since 2016, NMC has total capacity of 2,207 licensed beds across its network. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company provides a solid platform for continued growth in the GCC region's largest healthcare market. The NMC Health group treated over 7.5 million patients in 2018. The NMC Health group is also a leading UAE supplier of products and consumables coming from healthcare related products. NMC reported revenues of US$2.1 billion for the year ended 31 December 2018.
In April 2012, NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.
DISCLAIMER
This announcement does not constitute an invitation to participate in the Invitation in any jurisdiction and does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities. The distribution of this announcement in certain jurisdictions may be restricted by laws and regulations. Persons into whose possession this announcement comes are required by each of the Offeror, NMC and the Joint Dealer Managers to inform themselves about and to observe any such restrictions.
Each of Barclays Bank PLC and J.P. Morgan Cazenove is authorised by the Prudential Regulatory Authority and regulated by the Financial Conduct Authority and Prudential Regulatory Authority. Each of the Joint Dealer Managers is acting for the Offeror only in connection with the Invitation and will not be responsible to anyone other than the Offeror for providing the protections offered to its clients, nor for providing advice in relation to the Invitation or any matters referred to in this announcement.
The Joint Dealer Managers and their respective affiliates have provided, from time to time, and in the future may provide, certain commercial banking, investment banking and financial advisory services to the Offeror and its affiliates, for which they have received, and in the future will receive, customary fees. In the future, they may also provide investment banking and financial advisory services to the Offeror and its affiliates for customary fees. At any given time, the Joint Dealer Managers may trade the Bonds or other securities of the Offeror or its affiliates for its own account or for the accounts of customers, and, accordingly, may hold a long or short position in the Bonds or other securities of the Offeror or its affiliates, and may tender securities as part of the Invitation.